tetano
Editor, Senior Moderator
Clin Nurs Res
. 2021 Dec 26;10547738211064027.
doi: 10.1177/10547738211064027. Online ahead of print.
Maternal and Neonatal Outcomes of Healthy Pregnant Women With COVID-19 Versus High-risk Pregnant Women: A Multi-Center Case-Control Comparison Study
Iman Al Hashmi[SUP] 1 [/SUP], Atika Khalaf[SUP] 1 [/SUP], Vidya Seshan[SUP] 1 [/SUP], Hilal Alsabti[SUP] 2 [/SUP], Omar Al Omari[SUP] 1 [/SUP], Dalal Yehia[SUP] 3 [/SUP], Mohammed Baqer[SUP] 4 [/SUP], Jamal Al Khadhuri[SUP] 5 [/SUP]
Affiliations
Abstract
The purpose of this retrospective, matched case-control study (two controls [healthy control and high- risk control] vs. COVID-19 cases) was to compare the maternal and neonatal outcomes of pregnant women with and without COVID-19. A total of 261 pregnant women from three different countries with and without COVID-19 were included in this study. Several pregnancy complications were more common in high-risk pregnant women compared to COVID-19 cases and healthy pregnant women. These include preeclampsia (p < .01), vaginal bleeding (p < .05), preterm labor (p < .05), premature rupture of membrane (p < .01), requiring induction of labor (p < .05), have lower gestational age on delivery (F (2) = 3.1, p < .05), requiring cesarean section (p < .01), neonatal admission in the NICU (p < .01), and low neonatal Apgar score (p < .01). Nurses are advised to provide equal attention to pregnant women with underlying health issues and to pregnant women infected with COVID-19 in terms of the risk assessment, health care, and follow-up for optimal maternal and neonatal outcomes.
Keywords: COVID-19; comorbidities; coronavirus-19; maternal mortality; neonatal mortality; pregnant women.
. 2021 Dec 26;10547738211064027.
doi: 10.1177/10547738211064027. Online ahead of print.
Maternal and Neonatal Outcomes of Healthy Pregnant Women With COVID-19 Versus High-risk Pregnant Women: A Multi-Center Case-Control Comparison Study
Iman Al Hashmi[SUP] 1 [/SUP], Atika Khalaf[SUP] 1 [/SUP], Vidya Seshan[SUP] 1 [/SUP], Hilal Alsabti[SUP] 2 [/SUP], Omar Al Omari[SUP] 1 [/SUP], Dalal Yehia[SUP] 3 [/SUP], Mohammed Baqer[SUP] 4 [/SUP], Jamal Al Khadhuri[SUP] 5 [/SUP]
Affiliations
- PMID: 34955040
- DOI: 10.1177/10547738211064027
Abstract
The purpose of this retrospective, matched case-control study (two controls [healthy control and high- risk control] vs. COVID-19 cases) was to compare the maternal and neonatal outcomes of pregnant women with and without COVID-19. A total of 261 pregnant women from three different countries with and without COVID-19 were included in this study. Several pregnancy complications were more common in high-risk pregnant women compared to COVID-19 cases and healthy pregnant women. These include preeclampsia (p < .01), vaginal bleeding (p < .05), preterm labor (p < .05), premature rupture of membrane (p < .01), requiring induction of labor (p < .05), have lower gestational age on delivery (F (2) = 3.1, p < .05), requiring cesarean section (p < .01), neonatal admission in the NICU (p < .01), and low neonatal Apgar score (p < .01). Nurses are advised to provide equal attention to pregnant women with underlying health issues and to pregnant women infected with COVID-19 in terms of the risk assessment, health care, and follow-up for optimal maternal and neonatal outcomes.
Keywords: COVID-19; comorbidities; coronavirus-19; maternal mortality; neonatal mortality; pregnant women.